Korro Bio, Inc.

Korro Bio (KRRO) has reported zero cyber incidents and zero red-flag 8-K filings over the past 90 days, suggesting operational stability in the near term. However, the absence of recent events does not indicate overall risk profile; a limited observation window can mask longer-term structural concerns common in early-stage biotech. The full $49 Report extends analysis to 12 months of SEC filings, calculates dilution risk scores from equity issuance patterns, maps financing history and burn rates, and flags AI-detected stress signals in management disclosures. The full $49 Report adds comprehensive dilution modeling, 12-month filing context, capital structure risk assessment, and machine-detected narrative risk indicators.